172 related articles for article (PubMed ID: 25180293)
1. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
Zhao J; Giles BM; Taylor RL; Yette GA; Lough KM; Ng HL; Abraham LJ; Wu H; Kelly JA; Glenn SB; Adler AJ; Williams AH; Comeau ME; Ziegler JT; Marion M; Alarcón-Riquelme ME; ; Alarcón GS; Anaya JM; Bae SC; Kim D; Lee HS; Criswell LA; Freedman BI; Gilkeson GS; Guthridge JM; Jacob CO; James JA; Kamen DL; Merrill JT; Sivils KM; Niewold TB; Petri MA; Ramsey-Goldman R; Reveille JD; Scofield RH; Stevens AM; Vilá LM; Vyse TJ; Kaufman KM; Harley JB; Langefeld CD; Gaffney PM; Brown EE; Edberg JC; Kimberly RP; Ulgiati D; Tsao BP; Boackle SA
Ann Rheum Dis; 2016 Jan; 75(1):242-52. PubMed ID: 25180293
[TBL] [Abstract][Full Text] [Related]
2. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus.
Wu X; Jiang N; Deppong C; Singh J; Dolecki G; Mao D; Morel L; Molina HD
J Immunol; 2002 Aug; 169(3):1587-92. PubMed ID: 12133988
[TBL] [Abstract][Full Text] [Related]
3. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
[TBL] [Abstract][Full Text] [Related]
4. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein.
Boackle SA; Holers VM; Chen X; Szakonyi G; Karp DR; Wakeland EK; Morel L
Immunity; 2001 Nov; 15(5):775-85. PubMed ID: 11728339
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional effects of a lupus-associated polymorphism in the 5' untranslated region (UTR) of human complement receptor 2 (CR2/CD21).
Cruickshank MN; Karimi M; Mason RL; Fenwick E; Mercer T; Tsao BP; Boackle SA; Ulgiati D
Mol Immunol; 2012 Oct; 52(3-4):165-73. PubMed ID: 22673213
[TBL] [Abstract][Full Text] [Related]
7. Association of Complement Receptor 2 Gene Polymorphisms with Susceptibility to Osteonecrosis of the Femoral Head in Systemic Lupus Erythematosus.
Kim TH; Bae SC; Lee SH; Kim SY; Baek SH
Biomed Res Int; 2016; 2016():9208035. PubMed ID: 27446959
[TBL] [Abstract][Full Text] [Related]
8. Role of complement in the development of autoimmunity.
Boackle SA; Holers VM
Curr Dir Autoimmun; 2003; 6():154-68. PubMed ID: 12408051
[TBL] [Abstract][Full Text] [Related]
9. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus.
Taylor KE; Remmers EF; Lee AT; Ortmann WA; Plenge RM; Tian C; Chung SA; Nititham J; Hom G; Kao AH; Demirci FY; Kamboh MI; Petri M; Manzi S; Kastner DL; Seldin MF; Gregersen PK; Behrens TW; Criswell LA
PLoS Genet; 2008 May; 4(5):e1000084. PubMed ID: 18516230
[TBL] [Abstract][Full Text] [Related]
10. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.
Chen Z; Koralov SB; Kelsoe G
J Exp Med; 2000 Nov; 192(9):1339-52. PubMed ID: 11067882
[TBL] [Abstract][Full Text] [Related]
11. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.
Douglas KB; Windels DC; Zhao J; Gadeliya AV; Wu H; Kaufman KM; Harley JB; Merrill J; Kimberly RP; Alarcón GS; Brown EE; Edberg JC; Ramsey-Goldman R; Petri M; Reveille JD; Vilá LM; Gaffney PM; James JA; Moser KL; Alarcón-Riquelme ME; Vyse TJ; Gilkeson GS; Jacob CO; Ziegler JT; Langefeld CD; Ulgiati D; Tsao BP; Boackle SA
Genes Immun; 2009 Jul; 10(5):457-69. PubMed ID: 19387458
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
Salloum R; Franek BS; Kariuki SN; Rhee L; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
Arthritis Rheum; 2010 Feb; 62(2):553-61. PubMed ID: 20112359
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval.
Giles BM; Tchepeleva SN; Kachinski JJ; Ruff K; Croker BP; Morel L; Boackle SA
J Immunol; 2007 Apr; 178(7):4667-75. PubMed ID: 17372026
[TBL] [Abstract][Full Text] [Related]
14. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
15. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c.
Chen Y; Perry D; Boackle SA; Sobel ES; Molina H; Croker BP; Morel L
J Immunol; 2005 Jul; 175(2):1080-9. PubMed ID: 16002709
[TBL] [Abstract][Full Text] [Related]
16. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
17. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.
Wu H; Boackle SA; Hanvivadhanakul P; Ulgiati D; Grossman JM; Lee Y; Shen N; Abraham LJ; Mercer TR; Park E; Hebert LA; Rovin BH; Birmingham DJ; Chang DM; Chen CJ; McCurdy D; Badsha HM; Thong BY; Chng HH; Arnett FC; Wallace DJ; Yu CY; Hahn BH; Cantor RM; Tsao BP
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3961-6. PubMed ID: 17360460
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.
Palafox-Sánchez CA; Oregon-Romero E; Salazar-Camarena DC; Valle YM; Machado-Contreras JR; Cruz A; Orozco-López M; Orozco-Barocio G; Vázquez-Del Mercado M; Muñoz-Valle JF
Clin Exp Med; 2015 Nov; 15(4):439-46. PubMed ID: 25253090
[TBL] [Abstract][Full Text] [Related]
19. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
20. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
